PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Chew gum, lose weight

Syracuse University scientist uses vitamin B12 to orally deliver appetite-suppressing hormone

2011-11-22
(Press-News.org) Most people understand that serious weight loss requires changing attitudes toward what they eat and how often they exercise. But, what if the process could be aided by simply chewing a stick of gum after meals? That's the question a team of scientists, led by Syracuse University chemist Robert Doyle, is trying to answer. In a groundbreaking new study, Doyle's team demonstrated, for the first time, that a critical hormone that helps people feel "full" after eating can be delivered into the bloodstream orally. Doyle's study was published online Nov. 4, 2011 in the American Chemical Society's Journal of Medicinal Chemistry and is forthcoming in print. The journal is the most cited in the field and one of the leading primary research journals internationally. Doyle is an associate professor in the Department of Chemistry in SU's College of Arts and Sciences. He collaborated on the study with researchers from Murdoch University in Australia. The hormone, called human PYY, is part of a chemical system that regulates appetite and energy. When people eat or exercise, PYY is released into the bloodstream. The amount of PYY that is released increases with the number of calories that are consumed. Past studies have shown that people who are obese have lower concentrations of PYY in their bloodstream both when fasting and after eating than their non-obese counterparts. Additionally, intravenous infusion of PYY into a volunteer group of obese and non-obese individuals increased the serum levels of the hormone and lowered the number of calories both groups consumed. "PYY is an appetite-suppressing hormone," Doyle says. "But, when taken orally, the hormone is destroyed in the stomach and that which isn't destroyed has difficulty crossing into the bloodstream through the intestines." What's needed is a way to disguise the PYY so that it can travel through the digestive system relatively unharmed. Several years ago, Doyle developed a way to use vitamin B12 as a vehicle for the oral delivery of the hormone insulin. B12 is able to pass through the digestive system with relative ease and carry with it insulin, or other substances, into the bloodstream. Similarly, his research team attached the PYY hormone to his patent-pending vitamin B12 system. "Phase one of this study was to show that we could deliver a clinically relevant amount of PYY into the bloodstream," Doyle says. "We did that, and we are very excited by the results." The next step involves finding ways to insert the B12-PYY system into such things as chewing gum or an oral tablet to create a nutritional supplement to assist individuals in losing weight in much the same way as nicotine-laced gum is used to help people stop smoking. "If we are successful, PYY-laced gum would be a natural way to help people lose weight," he says. "They could eat a balanced meal, then chew a stick of gum. The PYY supplement would begin to kick in about three to four hours later, decreasing their appetite as they approach their next meal."

### END


ELSE PRESS RELEASES FROM THIS DATE:

New culprit found in Lou Gehrig's disease

2011-11-22
CHICAGO --- Following a major Northwestern Medicine breakthrough that identified a common converging point for all forms of amyotrophic lateral sclerosis (ALS and Lou Gehrig's disease), a new finding from the same scientists further broadens the understanding of why cells in the brain and spinal cord degenerate in the fatal disease. Less than three months ago, Northwestern research found that the crucial recycling system for cells in the brain and spinal cord was broken in people with ALS. And one mutated gene had a key role. Like a loafing worker, it wasn't doing its ...

Van Andel Institute study may lead to better, safer drug for diabetes

2011-11-22
Grand Rapids, Mich. (November 21, 2011) A Van Andel Research Institute (VARI) study published recently in the Journal of Biological Chemistry reveals that a natural fatty acid can serve as a regulator of blood sugar levels, which may have important applications in designing better and safer drugs for diabetes treatment. According to the U.S. Center for Disease Control and Prevention (CDC), nearly 26 million Americans have diabetes, and current drugs commonly used to treat the disease sometimes have unwanted side effects. The study found that decanoic acid, a saturated ...

New projection shows global food demand doubling by 2050

2011-11-22
Global food demand could double by 2050, according to a new projection by David Tilman, Regents Professor of Ecology in the University of Minnesota's College of Biological Sciences, and colleagues, including Jason Hill, assistant professor in the College of Food, Agricultural and Natural Resource Sciences. Producing that amount of food could significantly increase levels of carbon dioxide and nitrogen in the environment and cause the extinction of numerous species. But this can be avoided, the paper shows, if the high-yielding technologies of rich nations are adapted ...

New medical, research tool possible by probing cell mechanics

New medical, research tool possible by probing cell mechanics
2011-11-22
WEST LAFAYETTE, Ind. - Researchers are making progress in developing a system that measures the mechanical properties of living cells, a technology that could be used to diagnose human disease and better understand biological processes. The team used an instrument called an atomic force microscope to study three distinctly different types of cells to demonstrate the method's potentially broad applications, said Arvind Raman, a Purdue University professor of mechanical engineering. For example, the technique could be used to study how cells adhere to tissues, which is ...

Future prostate cancer treatments might be guided by math

2011-11-22
COLUMBUS, Ohio – Scientists have designed a first draft of a mathematical model that someday could guide treatment decisions for advanced prostate cancer, in part by helping doctors predict how individual patients will respond to therapy based on the biology of their tumors. These decisions would apply to treatment of cancer that has already spread beyond the prostate gland or that has recurred after initial treatments, such as surgery or radiation. Patients with this more advanced prostate cancer receive a therapy called androgen ablation, which inhibits production of ...

Use of technology-rich learning environment reveals improved retention rates

2011-11-22
Researchers at Rochester Institute of Technology have found that use of a technology-rich learning environment in several undergraduate engineering-technology courses has improved learning and decreased withdrawals from, or failing grades in, the courses. They found that more than 90 percent of students involved stated that using the technology-rich environment—which includes a combination of tablet PCs, collaborative software, and multiple projection screens capable of capturing and retaining graphics and notations—helped them learn and retain the information better ...

Life-threatening condition in preemies linked to blood type

2011-11-22
MAYWOOD, Ill. -- Many premature infants suffer a life-threatening destruction of intestinal tissue called necrotizing enterocolitis (NEC). Now a Loyola University Medical Center study has identified a major risk factor for NEC: Preemies with the AB blood type who develop NEC are nearly three times as likely to die from it as preemies with other blood types. The finding suggests that a simple change in blood transfusion practices in neonatal ICUs could significantly reduce the incidence of NEC. The study is published online ahead of print in the Journal of Perinatology. ...

Canadian breast cancer screening guidelines would cost thousands of lives

2011-11-22
The American College of Radiology today denounced new breast cancer screening guidelines by the Canadian Task Force on Preventive Health (CTFOPH), which recommend against annual screening of women ages 40-49 and would extend time between screens for older women. An ACR news release said "the CTFOPH guidelines ignore results of recent landmark randomized control trials which show that regular screening reduces breast cancer deaths in these women by approximately a third" and that "While implementation of the CTFOPH guidelines may save money on screening costs, the result ...

KLAS Offers Providers New Pharmacy-Focused Research

KLAS Offers Providers New Pharmacy-Focused Research
2011-11-22
Healthcare research firm KLAS announces a new pharmacy report designed to help providers attending the 2011 American Society of Health-System Pharmacists (ASHP) conference make informed pharmacy technology buying decisions. With thinning wallets, providers are becoming more strategic in their technology purchasing decisions--and pharmacy is no exception. The "KLAS Pharmacy Buyers Guide" offers product ratings for more than 100 software and equipment offerings, all based on the feedback of thousands of healthcare providers. Each rated product has been given ...

Late season Hurricane Kenneth forms in the eastern Pacific

Late season Hurricane Kenneth forms in the eastern Pacific
2011-11-22
The hurricane season in the eastern Pacific isn't over and Hurricane Kenneth serves as a reminder that the season ends November 30. NASA satellite imagery shows Kenneth more organized than it appeared on Sunday, Nov. 20 and became a late season hurricane earlier today. Kenneth began as the thirteenth tropical depression and that formed on Saturday, November 19, about 480 miles south of Acapulco, Mexico. On Sunday, November 29 at 0300 UTC (11 p.m. EST, Nov. 19) the National Hurricane Center noted that the center of Tropical Depression 13E was further north than previously ...

LAST 30 PRESS RELEASES:

Valvular heart disease is common in cancer patients but interventions improve survival

When socially responsible investing backfires

Cuffless blood pressure technologies in wearable devices show promise to transform care

AI-based tool predicts future cardiovascular events in patients with angina

Researchers map how the cerebellum builds its connections with the rest of the brain during early development

Routine scans could detect early prostate radiotherapy changes

Fairness in AI: Study shows central role of human decision-making

Pandemic ‘beneath the surface’ has been quietly wiping out sea urchins around the world

Tea linked to stronger bones in older women, while coffee may pose risks

School feeding programs lead to modest but meaningful results

Researchers develop AI Tool to identify undiagnosed Alzheimer's cases while reducing disparities

Seaweed based carbon catalyst offers metal free solution for removing antibiotics from water

Simple organic additive supercharges UV treatment of “forever chemical” PFOA

£13m NHS bill for ‘mismanagement’ of menstrual bleeds

The Lancet Psychiatry: Slow tapering plus therapy most effective strategy for stopping antidepressants, finds major meta-analysis

Body image issues in adolescence linked to depression in adulthood

Child sexual exploitation and abuse online surges amid rapid tech change; new tool for preventing abuse unveiled for path forward

Dragon-slaying saints performed green-fingered medieval miracles, new study reveals

New research identifies shared genetic factors between addiction and educational attainment

Epilepsy can lead to earlier deaths in people with intellectual disabilities, study shows

Global study suggests the underlying problems of ECT patients are often ignored

Mapping ‘dark’ regions of the genome illuminates how cells respond to their environment

ECOG-ACRIN and Caris Life Sciences unveil first findings from a multi-year collaboration to advance AI-powered multimodal tools for breast cancer recurrence risk stratification

Satellite data helps UNM researchers map massive rupture of 2025 Myanmar earthquake

Twisting Spins: Florida State University researchers explore chemical boundaries to create new magnetic material

Mayo Clinic researchers find new hope for toughest myeloma through off-the-shelf immunotherapy

Cell-free DNA Could Detect Adverse Events from Immunotherapy

American College of Cardiology announces Fuster Prevention Forum

AAN issues new guideline for the management of functional seizures

Could GLP-1 drugs affect risk of epilepsy for people with diabetes?

[Press-News.org] Chew gum, lose weight
Syracuse University scientist uses vitamin B12 to orally deliver appetite-suppressing hormone